NewEdge Wealth LLC Acquires Shares of 5,291 Cigna Group $CI

Posted by Brian Himes on Aug 22nd, 2026

NewEdge Wealth LLC bought a new position in shares of Cigna Group (NYSE:CI – Free Report) during the second quarter, Holdings Channel.com reports. The fund bought 5,291 shares of the health services provider’s stock, valued at approximately $1,459,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Assetmark Inc. boosted its stake in Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after purchasing an additional 5,963 shares during the period. HighTower Advisors LLC increased its stake in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after purchasing an additional 283,897 shares during the period. Handelsbanken Fonder AB raised its holdings in shares of Cigna Group by 12.1% in the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock valued at $22,833,000 after buying an additional 8,960 shares during the last quarter. KBC Group NV raised its holdings in shares of Cigna Group by 6.4% in the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after buying an additional 22,978 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Cigna Group by 41.1% during the fourth quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider’s stock worth $371,206,000 after buying an additional 392,978 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock valued at $6,386,550 in the last three months. 0.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CI shares. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. Wells Fargo & Company lifted their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. The Goldman Sachs Group boosted their target price on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Royal Bank Of Canada upped their price target on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Read Our Latest Research Report on CI

Cigna Group Stock Up 0.6%

Shares of NYSE CI opened at $276.19 on Friday. The firm has a 50-day moving average price of $284.20 and a 200 day moving average price of $281.38. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.94 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio is currently 25.82%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.